219 related articles for article (PubMed ID: 16508628)
1. The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas.
Hodul P; Malafa M; Choi J; Kvols L
Cancer Control; 2006 Jan; 13(1):61-71. PubMed ID: 16508628
[TBL] [Abstract][Full Text] [Related]
2. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
3. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
Strosberg JR; Choi J; Cantor AB; Kvols LK
Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
[TBL] [Abstract][Full Text] [Related]
4. Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
Hung JS; Chang MC; Lee PH; Tien YW
World J Surg; 2007 Dec; 31(12):2392-7. PubMed ID: 17960455
[TBL] [Abstract][Full Text] [Related]
5. Hepatic neuroendocrine metastases: does intervention alter outcomes?
Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
[TBL] [Abstract][Full Text] [Related]
6. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery.
Jaeck D; Oussoultzoglou E; Bachellier P; Lemarque P; Weber JC; Nakano H; Wolf P
World J Surg; 2001 Jun; 25(6):689-92. PubMed ID: 11376398
[TBL] [Abstract][Full Text] [Related]
7. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
8. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
10. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
11. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
12. [Surgical and adjuvant therapy of neuroendocrine tumors of the gastrointestinal tract and their metastases. A retrospective analysis of personal patient group].
Schmidbauer S; Ladurner R; Jückstock H; Trupka AW; Mussack T; Hallfeldt KK
Chirurg; 2001 Aug; 72(8):945-52. PubMed ID: 11554141
[TBL] [Abstract][Full Text] [Related]
13. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.
Blonski WC; Reddy KR; Shaked A; Siegelman E; Metz DC
World J Gastroenterol; 2005 Dec; 11(48):7676-83. PubMed ID: 16437698
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes.
Henn AR; Levine EA; McNulty W; Zagoria RJ
AJR Am J Roentgenol; 2003 Oct; 181(4):1005-10. PubMed ID: 14500219
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Tumors.
Basuroy R; Srirajaskanthan R; Ramage JK
Gastroenterol Clin North Am; 2016 Sep; 45(3):487-507. PubMed ID: 27546845
[TBL] [Abstract][Full Text] [Related]
17. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors.
Curtiss SI; Mor E; Schwartz ME; Sung MW; Hytiroglou P; Thung SN; Sheiner PA; Emre S; Miller CM
J Am Coll Surg; 1995 Feb; 180(2):184-7. PubMed ID: 7850052
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
Mazzaglia PJ; Berber E; Milas M; Siperstein AE
Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
[TBL] [Abstract][Full Text] [Related]
19. Malignant rectal carcinoid: a sequential multidisciplinary approach for successful treatment of hepatic metastases.
Azizkhan RG; Tegtmeyer CJ; Wanebo HJ
Am J Surg; 1985 Feb; 149(2):210-4. PubMed ID: 3970317
[TBL] [Abstract][Full Text] [Related]
20. Hepatic cytoreductive surgery for neuroendocrine cancer.
Wright BE; Lee CC; Bilchik AJ
Surg Oncol Clin N Am; 2007 Jul; 16(3):627-37, ix-x. PubMed ID: 17606197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
